Anti-TIGIT Antibody (Tiragolumab)
Catalog No.
F1488
Anti-TIGIT Antibody (Tiragolumab)
Featured Products
Tiragolumab is an immune checkpoint inhibitor that binds to the T cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab alone or in combination with the PD-L1 inhibitor atezolizumab may be effective against a variety of solid malignancies, especially non-small cell lung cancer (NSCLC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
148.66 kDa
Dry ice
1918185-84-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RG6058, MTIG7192A, RO7092284
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q495A1
Human, Mouse, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human TIGIT His at 2 ug/mL can bind Anti-TIGIT Antibody (Tiragolumab)
TIGIT
Please avoid freeze-thaw cycles.